Clinical Trial Update: Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing neoadjuvant DOS versus SOX in locally advanced gastric adenocarcinoma (Phase 2/3). Status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Snippet

Sponsor: Peking University | Conditions: Gastric Adenocarcinoma | Phase 2, Phase 3 | Status: UNKNOWN